Basic Care No Drip Nasal Spray Recalled for Contaminated Excipient
Perrigo Company is recalling 37,104 bottles of Basic Care No Drip Nasal Spray (oxymetazoline hydrochloride 0.05%) nationwide due to contaminated excipient used during manufacturing. The affected batches were distributed to U.S. consumers.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving CGMP deviations (use of a recalled contaminated excipient). The source text does not report any illnesses, injuries, or adverse events, and the hazard appears to be precautionary in nature. Class II recalls without reported harm typically score 2 under the rubric.
Plain-English summary
Perrigo Company PLC is recalling Basic Care No Drip Nasal Spray, Maximum Strength Plus Menthol No Drip Nasal Spray (oxymetazoline hydrochloride 0.05%), distributed by Amazon.com Services LLC. A total of 37,104 bottles are affected by this recall.
The recall was initiated because the product was manufactured using a contaminated excipient that had been recalled from the excipient supplier. This represents a current good manufacturing practices (CGMP) deviation.
The affected product was distributed nationwide in the United States. The affected batches are: Batch 1FK1251 (Exp 02/28/2023) and Batch 1BK0716 (Exp 12/31/2022). The product is packaged as 1 FL Oz (30 mL) per bottle with NDC 72288-703-10.
Consumers who have purchased this product should stop use and consult their healthcare provider if they have any questions or concerns.
The recalled product
- Product
- BASIC CARE NO DRIP NASAL (OXYMETAZOLINE HYDROCHLORIDE)
- Brand
- BASIC CARE NO DRIP NASAL
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Nasal Decongestant
- Affected units
- 37,104
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Batch: 1FK1251
- Exp 02/28/2023
- 1BK0716
- Exp 12/31/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 51 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 51 products in this recall →Related recalls
Same brand · BASIC CARE NO DRIP NASAL
- ModerateBasic Care No Drip Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateOxymetazoline Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · contaminated excipient
See all →- ModerateEquate Children's Pain and Fever recalled due to contaminated excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Infant Pain and Fever Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
Similar recalls
- ModerateRexall Nasal Spray Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2018-10-24
- ModerateOTC Nasal Decongestant Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
- ModerateFDA Recalls Premier Value Nasal Spray Due to Manufacturing Deviations
FDA (Drugs) · 2018-10-24
- ModerateOxymetazoline Nasal Spray Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
- ModerateNasal Decongestant Recalled for Possible Manufacturing Water Contamination
FDA (Drugs) · 2024-01-10
- ModerateWalgreens Severe Anefrin Nasal Spray Recalled for Quality Deviations
FDA (Drugs) · 2018-10-24